Search Results | Diabetes Care | American Diabetes Association

1-20 of 55

2 3

Sort by

Sort Order Select

Journal Articles

Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy

Julian W. Sacre, Dianna J. Magliano, Jonathan E. Shaw

Diabetes Care 2022;45(8):1900–1906

DOI: https://doi.org/10.2337/dc21-1929

Published: 26 July 2022

View article

Journal Articles

Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African Americans

Sanjoy K. Paul, Jonathan E. Shaw, Peter Fenici, Olga Montvida

Diabetes Care 2022;45(8):1873–1881

DOI: https://doi.org/10.2337/dc21-2349

Published: 26 July 2022

View article

Journal Articles

Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019

Jedidiah I. Morton, Peter A. Lazzarini, Jonathan E. Shaw, Dianna J. Magliano

Diabetes Care 2022;45(4):789–797

DOI: https://doi.org/10.2337/dc21-2268

Published: 27 January 2022

View article

Journal Articles

Paul Zimmet: A Voice for Diabetes

Jonathan E. Shaw

Diabetes Care 2021;44(11):2460–2463

DOI: https://doi.org/10.2337/dci21-0040

Published: 18 October 2021

View article

Journal Articles

Projecting the Incidence of Type 2 Diabetes–Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment

Jedidiah I. Morton, Stephen P. McDonald, Agus Salim, Danny Liew, Jonathan E. Shaw, Dianna J. Magliano

Diabetes Care 2021;44(7):1515–1523

DOI: https://doi.org/10.2337/dc21-0220

Published: 23 May 2021

View article

Journal Articles

Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616

Thirunavukkarasu Sathish, Jonathan E. Shaw, Brian Oldenburg, Ajay Mahal

Diabetes Care 2020;43(12):e204–e205

DOI: https://doi.org/10.2337/dc20-2124

Published: 12 November 2020

View article

Journal Articles

Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials

Julian W. Sacre, Dianna J. Magliano, Jonathan E. Shaw

Diabetes Care 2020;43(10):2614–2623

DOI: https://doi.org/10.2337/dc20-0654

Published: 11 September 2020

View article

Journal Articles

The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study

Jedidiah I. Morton, Danny Liew, Stephen P. McDonald, Jonathan E. Shaw, Dianna J. Magliano

Diabetes Care 2020;43(8):1788–1795

DOI: https://doi.org/10.2337/dc20-0352

Published: 15 June 2020

View article

Journal Articles

Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Oyunchimeg Buyadaa, Dianna J. Magliano, Agus Salim, Digsu N. Koye, Jonathan E. Shaw

Diabetes Care 2020;43(1):122–129

DOI: https://doi.org/10.2337/dc19-1438

Published: 03 December 2019

View article

Includes: Supplementary data

Journal Articles

Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE–I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476–485

Ambady Ramachandran, Chamukuttan Snehalatha, Jonathan E. Shaw, Priscilla Susairaj, Mary Simon, Lakshminarayanan Vijaya, Krishnamoorthy Satheesh, Ramachandran Vinitha, Arun Raghavan, Arun Nanditha

Diabetes Care 2019;42(8):e139–e140

DOI: https://doi.org/10.2337/dci19-0027

Published: 12 July 2019

View article

Journal Articles

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial

Toshiaki Ohkuma, Min Jun, Mark Woodward, Sophia Zoungas, Mark E. Cooper, Diederick E. Grobbee, Pavel Hamet, Giuseppe Mancia, Bryan Williams, Paul Welsh, Naveed Sattar, Jonathan E. Shaw, Kazem Rahimi, John Chalmers

Diabetes Care 2017;40(9):1203–1209

DOI: https://doi.org/10.2337/dc17-0509

Published: 06 July 2017

View article

Includes: Supplementary data

Journal Articles

Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People

Jessica L. Harding, Jonathan E. Shaw, Anna Peeters, Susan Davidson, Dianna J. Magliano

Diabetes Care 2016;39(6):1018–1026

DOI: https://doi.org/10.2337/dc15-2308

Published: 26 April 2016

View article

Includes: Supplementary data

Journal Articles

Diabetes in Asia and the Pacific: Implications for the Global Epidemic

Arun Nanditha, Ronald C.W. Ma, Ambady Ramachandran, Chamukuttan Snehalatha, Juliana C.N. Chan, Kee Seng Chia, Jonathan E. Shaw, Paul Z. Zimmet

Diabetes Care 2016;39(3):472–485

DOI: https://doi.org/10.2337/dc15-1536

Published: 12 February 2016

View article

Journal Articles

Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes

Dianna Josephine Magliano, Jessica L. Harding, Kerryn Cohen, Rachel R. Huxley, Wendy A. Davis, Jonathan E. Shaw

Diabetes Care 2015;38(7):1274–1280

DOI: https://doi.org/10.2337/dc14-2820

Published: 12 June 2015

View article

Includes: Supplementary data

Journal Articles

Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation. Diabetes Care 2015;38: 264–270

Jessica L. Harding, Jonathan E. Shaw, Anna Peeters, Bendix Cartensen, Dianna J. Magliano

Diabetes Care 2015;38(4):734–735

DOI: https://doi.org/10.2337/dc15-er04a

Published: 14 March 2015

View article

Journal Articles

Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010. Diabetes Care 2014;37: 2579–2586

Jessica L. Harding, Jonathan E. Shaw, Anna Peeters, Tenniel Guiver, Susan Davidson, Dianna J. Magliano

Diabetes Care 2015;38(4):733–734

DOI: https://doi.org/10.2337/dc15-er04

Published: 14 March 2015

View article

Journal Articles

Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation

Jessica L. Harding, Jonathan E. Shaw, Anna Peeters, Bendix Cartensen, Dianna J. Magliano

Diabetes Care 2015;38(2):264–270

DOI: https://doi.org/10.2337/dc14-1996

Published: 08 December 2014

View article

Includes: Supplementary data

Journal Articles

Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010

Jessica L. Harding, Jonathan E. Shaw, Anna Peeters, Tenniel Guiver, Susan Davidson, Dianna J. Magliano

Diabetes Care 2014;37(9):2579–2586

DOI: https://doi.org/10.2337/dc14-0096

Published: 07 August 2014

View article

Includes: Supplementary data

Journal Articles

Diabetes Prevention and Treatment Strategies: Are we doing enough?

Kathryn Backholer, PHD, Anna Peeters, PHD, William H. Herman, MD, Jonathan E. Shaw, FRACP, Danny Liew, PHD, Zanfina Ademi, PHD, Dianna J. Magliano, PHD

Diabetes Care 2013;36(9):2714–2719

DOI: https://doi.org/10.2337/DC12-2501

Published: 13 August 2013

View article

Includes: Supplementary data

Journal Articles

Glucose-Independent Ethnic Differences in HbA_1c in People Without Known Diabetes

Matthew J.L. Hare, MBBS, Dianna J. Magliano, PHD, Paul Z. Zimmet, FRACP, Stefan Söderberg, PHD, Noorjehan Joonas, PHD, Vassen Pauvaday, FRCP, José Larhubarbe, BSC, Jaakko Tuomilehto, PHD, Sudhir Kowlessur, DIP PUB HEALTH ADMIN, K. George M.M. Alberti, FRCP, Jonathan E. Shaw, FRACP

Diabetes Care 2013;36(6):1534–1540

DOI: https://doi.org/10.2337/dc12-1210

Published: 15 May 2013

View article

2 3

NARROW

Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy

Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African Americans

Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019

Paul Zimmet: A Voice for Diabetes

Projecting the Incidence of Type 2 Diabetes–Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment

Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616

Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials

The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study

Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE–I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476–485

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial

Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People

Diabetes in Asia and the Pacific: Implications for the Global Epidemic

Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes

Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation. Diabetes Care 2015;38: 264–270

Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010. Diabetes Care 2014;37: 2579–2586

Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation

Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010

Diabetes Prevention and Treatment Strategies: Are we doing enough?

Glucose-Independent Ethnic Differences in HbA_1c in People Without Known Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only